A5050553927- Opioid Use Disorder Treatment
- Substance Abuse Treatment and Outcomes
- Prenatal Substance Exposure Effects
- Pain Management and Opioid Use
- Pharmaceutical Practices and Patient Outcomes
- Maternal Mental Health During Pregnancy and Postpartum
- Health Policy Implementation Science
- Musculoskeletal pain and rehabilitation
- Primary Care and Health Outcomes
- HIV, Drug Use, Sexual Risk
- Emergency and Acute Care Studies
- Gestational Diabetes Research and Management
- Pediatric Pain Management Techniques
- Cardiac Arrest and Resuscitation
- Poisoning and overdose treatments
- Homelessness and Social Issues
- Cannabis and Cannabinoid Research
- Healthcare professionals’ stress and burnout
- Healthcare Policy and Management
- Social Work Education and Practice
- Migration, Health and Trauma
- Trauma and Emergency Care Studies
- Alcohol Consumption and Health Effects
- Smoking Behavior and Cessation
- Injury Epidemiology and Prevention
University of Utah Health Care
2025
University of Utah
2018-2024
Intermountain Healthcare
2019-2024
VA Salt Lake City Healthcare System
2019-2024
Community Link
2022-2023
ARUP Laboratories (United States)
2022
University of Pittsburgh
2013-2021
Pennsylvania Department of Drug and Alcohol Programs
2021
Pennsylvania Department of Human Services
2021
National Institute on Drug Abuse
2017
<h3>Importance</h3> Current approaches to identifying individuals at high risk for opioid overdose target many patients who are not truly risk. <h3>Objective</h3> To develop and validate a machine-learning algorithm predict among Medicare beneficiaries with least 1 prescription. <h3>Design, Setting, Participants</h3> A prognostic study was conducted between September 1, 2017, December 31, 2018. Participants (n = 560 057) included fee-for-service without cancer filled or more prescriptions...
Abstract Background and aims Uncertainty about optimal treatment duration for buprenorphine opioid agonist therapy may lead to substantial variation in provider payer decision‐making regarding course. We aimed identify distinct trajectories of use examine outcomes associated with these guide health system interventions length. Design Retrospective cohort study. Setting US Pennsylvania Medicaid. Patients A total 10 945 enrollees aged 18–64 years initiating between 2007 2012. Measurements...
Pregnancy is an opportune time to identify opioid dependence, facilitate conversion maintenance treatment, and coordinate care with specialists in addiction medicine, behavioral health, social services. Comprehensive prenatal for opioid-dependent women involves the evaluation management of co-occurring psychiatric disorders, polysubstance use, infectious diseases, stressors, counseling regarding importance breastfeeding, contraception, neonatal abstinence syndrome. Although complex...
This study uses Medicaid data to compare prescription opioid use, duration of and rates medication-assisted treatment (buprenorphine, methadone, or naltrexone) among enrollees before after an overdose event.
Use of buprenorphine - an effective treatment for opioid use disorders (OUDs) has increased rapidly in recent years and is often financed by Medicaid. We investigated predictors treatment, patterns care, quality care a large state Medicaid program.Data from Pennsylvania 2007 to 2012 provided information regarding diagnoses, demographic characteristics, enrollment, inpatient outpatient services, prescription drugs. identified adult enrollees using buprenorphine, examined prevalence OUD...
Background: Health systems may play an important role in identification of patients at-risk opioid medication overdose. However, standard measures for identifying overdose risk administrative data do not exist. Objective: Examine the association between and 2 validated nonmedical use prescription opioids within claims data. Research Design: A longitudinal retrospective cohort study that estimated associations use. Subjects: Adult Pennsylvania Medicaid program 2007–2012 initiating treatment...
Objective To develop and validate a machine-learning algorithm to improve prediction of incident OUD diagnosis among Medicare beneficiaries with ≥1 opioid prescriptions. Methods This prognostic study included 361,527 fee-for-service beneficiaries, without cancer, filling prescriptions from 2011–2016. We randomly divided into training, testing, validation samples. measured 269 potential predictors including socio-demographics, health status, patterns use, provider-level regional-level factors...
<title>Abstract</title> Background Medical Cannabis (MC) is authorized in numerous state-legislated programs to treat approved medical conditions. Notwithstanding MC access, some participants continue use cannabis purchased outside of a state licensed pharmacy, otherwise known as illicit medicinal (IMC), their Identifying barriers and contributors motives for IMC can promote safety, improve program design, inform future research efforts. Methods This exploratory analysis utilized baseline...
Objective: We aimed to understand clinician perceptions of nudge interventions designed prevent unsafe opioid prescribing for acute pain in primary care. Design: Semistructured interviews were conducted. Setting: Forty-eight practices across three healthcare systems included. Participants: Primary care clinicians who exposed as part a randomized clinical trial Interventions: Intervention arms included an electronic health record alert upon new either alone or with one both (written...
In the USA prescription opioids, which are misused or abused by some patients, often obtained from pharmacies. However, screening and brief intervention (SBI) for opioid misuse has not been tested in this setting. The goal of project was to assess pharmacists' attitudes motivation towards delivering SBI abuse. A descriptive cross-sectional online survey administered pharmacists Utah Texas, USA. assessed pharmacists': (1) interest addressing abuse; (2) beliefs about whether pharmacies may be...
Prescription opioid (PO) abuse has reached epidemic proportions in the United States, and pharmacies are locations from which these medications often diverted. This study identifies factors associated with pharmacists who currently screen discuss PO misuse patients.A secondary data analysis of a cross-sectional Web-based survey that was sent to conducted. The contained items assessed whether screened discussed patients along pharmacists' attitudes beliefs toward providing brief...
Limited research is available regarding the health risks associated with opioid medication misuse among middle age (50-64 years) and older adults (65 older). Understanding symptom risk profiles of these populations has potential to advance national epidemic response. A survey was conducted in four community pharmacies southwestern Pennsylvania adult, non-cancer patients filling medications (N = 318) symptoms factors. Descriptive multivariate statistical analyses compared respondent...